VKTX ▲ +1.0% - Viking Therapeutics, Inc.
$VKTX VKTX - Viking Therapeutics Announces Initiation of VK2735 Oral Maintenance Dosing Clinical Trial in Patients with Obesity
06-OCT-2026 07:05 AM ET
Share this post
More filings for $VKTX
VKTX ▲ +5.4% - Viking Therapeutics, Inc.Nov 15, 2026VKTX ▲ +1.6% - Viking Therapeutics, Inc.Nov 9, 2026VKTX - Viking Therapeutics, Inc. - SEC Filing Update (05-NOV-2026) | ThinkSabio - Stocks SimplifiedNov 5, 2026VKTX ▼ -2.0% - Viking Therapeutics, Inc.Nov 3, 2026VKTX ▲ +0.6% - Viking Therapeutics, Inc.Oct 28, 2026VKTX ▼ -1.2% - Viking Therapeutics, Inc.Oct 21, 2026
View full $VKTX filing history →💬 Comments
Loading comments…
Leave a comment